Mohamed S Abdelfattah Selected Research

Mohamed S Abdelfattah Research Topics

7	Adenocarcinoma 07/2017 - 03/2008
4	Breast Neoplasms (Breast Cancer) 11/2022 - 09/2008
3	Neoplasms (Cancer) 11/2022 - 07/2016
2	Body Weight (Weight, Body) 10/2022 - 01/2020
2	Carcinoma (Carcinomatosis) 01/2021 - 01/2013
1	Obesity 10/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2022
1	Colitis 08/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Neuroinflammatory Diseases 01/2020
1	Huntington Disease (Huntington's Disease) 01/2020
1	Inflammation (Inflammations) 01/2019
1	Stomach Ulcer (Gastric Ulcer) 01/2019
1	Lung Neoplasms (Lung Cancer) 09/2008
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2008
1	Colonic Neoplasms (Colon Cancer) 03/2008

6	LigandsIBA 07/2017 - 03/2011
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2017 - 03/2011
2	Antineoplastic Agents (Antineoplastics)IBA 11/2022 - 06/2017
2	SeleniumIBA 08/2022 - 01/2020
2	Apoptosis Regulatory ProteinsIBA 08/2022 - 01/2016
2	Biological ProductsIBA 07/2016 - 03/2008
1	Fluorouracil (Carac)FDA LinkGeneric 11/2022
1	Pharmaceutical PreparationsIBA 11/2022
1	EnzymesIBA 10/2022
1	FlavonoidsIBA 10/2022
1	Insulin (Novolin)FDA Link 10/2022
1	LeptinIBA 10/2022
1	Acetic Acid (Vinegar)FDA LinkGeneric 08/2022
1	ProdigiosinIBA 08/2022
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 08/2022
1	Caspase 3 (Caspase-3)IBA 08/2022
1	erucylphosphocholineIBA 01/2021
1	heliomycinIBA 01/2021
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2021
1	3-nitropropionic acidIBA 01/2020
1	Rutin (Rutoside)IBA 01/2020
1	Neuroprotective AgentsIBA 01/2020
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2019
1	Omeprazole (Prilosec)FDA LinkGeneric 01/2019
1	NF-kappa B (NF-kB)IBA 01/2019
1	AcidsIBA 01/2019
1	Heme Oxygenase-1IBA 01/2019
1	Complex MixturesIBA 06/2017
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	maroxazinoneIBA 01/2013
1	TNF-Related Apoptosis-Inducing LigandIBA 12/2010
1	moromycin BIBA 09/2008
1	steffimycinIBA 03/2008

1	Therapeutics 06/2017